Development of Non-Polyamine based Polyamine Transport Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Moots, Holly [1 ]
Phanstiel, Otto [1 ]
机构：
[1] Univ Cent Florida, Med Educ, Orlando, FL 32816 USA
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
652.13
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SYNERGISTIC ANTITUMOR EFFICACY OF GEMCITABINE AND CISPLATIN TO INDUCE FERROPTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA VIA SAT1-POLYAMINE METABOLISM PATHWAY
    Wei, Wanhui
    Lu, Yuanyuan
    Hu, Qian
    Zhang, Heng
    Zhao, Qiu
    Liu, Lan
    GASTROENTEROLOGY, 2023, 164 (06) : S772 - S773
  • [32] TGF- Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
    Alvarez, Marcus A.
    Freitas, Julia Pedo
    Hussain, S. Mazher
    Glazer, Evan S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (02) : 207 - 213
  • [33] Synthesis of spermidine and norspermidine dimers as high affinity polyamine transport inhibitors
    Covassin, L
    Desjardins, M
    Charest-Gaudreault, R
    Audette, M
    Bonneau, MJ
    Poulin, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (12) : 1709 - 1714
  • [34] Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
    Reigada, Chantal
    Saye, Melisa
    Phanstiel, Otto
    Valera-Vera, Edward
    Miranda, Mariana R.
    Pereira, Claudio A.
    FRONTIERS IN MEDICINE, 2019, 6
  • [35] TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
    Marcus A. Alvarez
    Júlia Pedó Freitas
    S. Mazher Hussain
    Evan S. Glazer
    Journal of Gastrointestinal Cancer, 2019, 50 : 207 - 213
  • [36] DEVELOPMENT OF SPECIFIC INHIBITORS OF ANIMAL POLYAMINE BIOSYNTHETIC-ENZYMES
    WILLIAMSASHMAN, HG
    CORTI, A
    TADOLINI, B
    ITALIAN JOURNAL OF BIOCHEMISTRY, 1976, 25 (01): : 5 - 32
  • [37] Ion transport proteins control pancreatic ductal adenocarcinoma
    Schwab, A.
    Stock, C.
    Swietach, P.
    Hulikova, A.
    Vaughan-Jones, R.
    Pedersen, S. F.
    Andersen, A. D.
    Hoffmann, E.
    Novak, I
    Reshkin, S.
    Prevarskaya, N.
    Lemonnier, L.
    A-S, Borowiec
    Arcangeli, A.
    Zanieri, F.
    D'Amico, M.
    Fraser, S. P.
    Djamgoz, M. B.
    Alves, F.
    Kalthoff, H.
    Pardo, L.
    Stuehmer, W.
    ONKOLOGIE, 2010, 33 : 269 - 269
  • [38] Circadian Disruption in the Development of Pancreatic Ductal Adenocarcinoma
    Schwartz, P. B.
    Walcheck, M. T.
    Carrillo, N. D.
    Matkowskyj, K. A.
    Ronnekleiv-Kelly, S.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S189 - S189
  • [39] Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma
    Gendron, Liberty N.
    Sheveland, Colter G.
    Gunn, Jason R.
    Pogue, Brian W.
    Shell, Thomas A.
    Shell, Jennifer R.
    MOLECULAR PHARMACEUTICS, 2023, 21 (01) : 137 - 142
  • [40] In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma
    Sheth, Gaurav
    Shah, Shailesh R.
    Sengupta, Prabal
    Jarag, Tushar
    Chimanwala, Sabbirhusen
    Sairam, Kalapatapu V. V. M.
    Jain, Vaibhav
    Talwar, Rashmi
    Dhanave, Avinash
    Raviya, Mehul
    Menon, Soumya
    Trivedi, Shivangi
    Chitturi, Trinadha Rao
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (01): : 41 - 50
12345